CN Stock MarketDetailed Quotes

600276 Jiangsu Hengrui Pharmaceuticals

Watchlist
  • 44.77
  • -0.20-0.44%
Market Closed Sep 13 15:00 CST
285.59BMarket Cap52.61P/E (TTM)

Jiangsu Hengrui Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Jiangsu Hengrui Pharmaceuticals Q2 2024 Earnings Date

Currency：CNYAug 22, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
6.65B
7.60B
+955.60M
Beat Est.
+17.12%
+33.95%
+14.38%
Net Income
--
2.06B
--
+94.95%
Analyst Rating
Strong Buy

Sep 15, 2024

Jiangsu Hengrui Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 4 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 6.667B--
--2024/Q3-- / 6.737B--
Aug 22, 20242024/Q27.603B / 6.648B--
Apr 18, 20242024/Q15.998B / 6.071B--
--2023/Q45.806B / 6.199B--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 6.667B--
--2024/Q3-- / 6.737B--
Aug 22, 20242024/Q27.603B / 6.648B--
Apr 18, 20242024/Q15.998B / 6.071B--
--2023/Q45.806B / 6.199B--

Unlock Free Earnings Estimates

Jiangsu Hengrui Pharmaceuticals Earnings Reports

  • Jiangsu Hengrui Pharmaceuticals Semi-Annual Report for 2024

    Aug 21 12:00 ET

  • Jiangsu Hengrui Pharmaceuticals 2024 Interim Report Summary

    Aug 21 12:00 ET

  • Summary of Hengrui Pharmaceutical's 2023 Annual Report

    Apr 17 12:00 ET

  • Hengrui Pharmaceutical 2023 Annual Report

    Apr 17 12:00 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Sep 15, 2024

    Strong Buy

    • Strong Buy

      85.71%

    • Buy

      10.71%

    • Hold

      3.57%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    CN
    Overall
    Symbol
    Latest Price
    % Chg

    No Data